(Q34106530)

31 July 2017

1 reference

title

Molecular control of bone remodeling and osteoporosis (English)

1 reference

31 July 2017

0 references

2

Penninger JM

1 reference

31 July 2017

Kong YY

1

1 reference

PubMed ID

11121682

31 July 2017

language of work or name

1 reference

1 October 2000

1 reference

31 July 2017

Experimental Gerontology

1 reference

31 July 2017

35

1 reference

31 July 2017

947-956

1 reference

31 July 2017

8

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

RANK is essential for osteoclast and lymph node development

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Requirement for NF-kappaB in osteoclast and B-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Cell biology of the osteoclast

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

RANKing the importance of measles virus in Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Bone cancer gain without the pain

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2800%2900178-9

7 January 2021

10.1016/S0531-5565(00)00178-9

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11121682